checkAd

    EQS-Adhoc  199  0 Kommentare Achiko AG appoints Toolbox Medical Innovations and NDA Group and expands Advisory Board - Seite 2

    - Mr. Charles Pan has over 25 years of professional venture and private equity investment experience in East Asia and Silicon Valley, and held positions as Chief Executive Officer at Orange Capital, Special Assistant to the Chairman and Investment Director at Foxconn's mobile business, and Chief Investment Officer at Eastern Media Group. His experience covers Investment/M&A, strategic partnership, startup management and ecosystem building with successful investments in multiple unicorn companies. He was recognised in 2016 and 2017 on the "Powerlist 100" investors by Global Corporate Venturing.

     

    About Achiko AG
    Headquartered in Switzerland, with a global market focus, Achiko AG (SWX:ACHI, ISIN CH0522213468) is an entrepreneurial platform company, utilising the knowledge and experience of its people and key technologies to enable transformation in various industries.

    Through innovations in technology along with the company's unique operating footprint from Europe to Asia, Achiko seeks to transform markets and bring exceptional value to its customers, people, and shareholders. Achiko supports innovations in healthcare through its Teman Sehat ("Health Buddy") ecosystem and a novel saliva based Covid-19 testing technology, codenamed "Gumnuts", being developed with Regenacellx.sl.

    For any inquiries regarding Gumnuts or Teman Sehat, please contact info@achiko.com

    Further information about Achiko can be found at https://www.achiko.com

    Further information about the Teman Sehat ecosystem can be found at https://www.temansehat.co

    Further information about Regenacellex.sl can be found at https://regenacellx.com

    Further information about Toolbox can be found here: https://www.toolboxmed.com

    Further information about NDA Group can be found here: https://www.ndareg.com

    Investor Relations & Press Contacts:

    Investor Relations
    ACHIKO AG

    Investor Relations
    E: ir@achiko.com

    Press Contact Switzerland
    Marcus Balogh
    Farner Consulting Ltd.
    E: achiko@farner.ch
    T: +41 44 266 67 67

    Press Contact Germany and Austria
    Axel Mühlhaus / Dr Sönke Knop
    edicto GmbH
    E: achiko@edicto.de

    Seite 2 von 3


    Aktuelle Themen


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc Achiko AG appoints Toolbox Medical Innovations and NDA Group and expands Advisory Board - Seite 2 EQS Group-Ad-hoc: Achiko AG / Key word(s): Development of Sales Achiko AG appoints Toolbox Medical Innovations and NDA Group and expands Advisory Board 02-Nov-2020 / 05:49 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer …

    Schreibe Deinen Kommentar

    Disclaimer